The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
Abstract
The dystrophin deficiency leading to the severely progressing muscle degeneration in Duchenne muscular dystrophy (DMD) patients is caused by frame-shifting mutations in the DMD gene. We are developing a reading frame correction therapy aimed at the antisense-induced skipping of targeted exons from the pre-mRNA. Despite introducing a (larger) deletion, an in-frame transcript is generated that allows the synthesis of a slightly shorter, but largely functional dystrophin as found in the mostly milder Becker muscular dystrophy (BMD). We have recently demonstrated both the efficacy and high efficiency of the antisense-induced skipping of numerous exons from the DMD transcript in control muscle cells. In principle, this would restore the reading frame in over 75% of the patients reported in the Leiden DMD mutation database. In this study, we in fact demonstrate the broad therapeutic applicability of this strategy in cultured muscle cells from six DMD patients carrying different deletions and a nonsense mutation. In each case, the specific skipping of the targeted exon was induced, restoring dystrophin synthesis in over 75% of cells. The protein was detectable as soon as 16 h post-transfection, then increased to significant levels at the membrane within 2 days, and was maintained for at least a week. Finally, its proper function was further suggested by the restored membranal expression of four associated proteins from the dystrophin-glycoprotein complex. These results document important progress towards a clinically applicable, small-molecule based therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209
Emery, A. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07815-7 · Cited by 1,667
The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
Koenig, M., Monaco, A. P., & Kunkel, L. M. (1988) · Cell · doi:10.1016/0092-8674(88)90383-2 · Cited by 1,538
Membrane organization of the dystrophin-glycoprotein complex
Ervasti, J. M., & Campbell, K. P. (1991) · Cell · doi:10.1016/0092-8674(91)90035-w · Cited by 1,329
Monaco, A. P., Bertelson, C. J., Liechti-Gallati, S., Moser, H., & Kunkel, L. M. (1988) · Genomics · doi:10.1016/0888-7543(88)90113-9 · Cited by 1,210
Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., Müller, C. R., Lindlöf, M., Kääriäinen, H. A., et al. (1989) · Europe PMC (PubMed Central) · Cited by 1,113
Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
Ervasti, J. M., Ohlendieck, K., Kahl, S. D., Gaver, M. G., & Campbell, K. P. (1990) · Nature · doi:10.1038/345315a0 · Cited by 1,025
Rando, T. A., & Blau, H. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.6.1275 · Cited by 936
Hoffman, E. P., Fischbeck, K. H., Brown, R. H., Johnson, M., Medori, R., Loire, J. D., Harris, J. B., Waterston, R., Brooke, M., Specht, L., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182104 · Cited by 927
den Dunnen, J. T., Grootscholten, P. M., Bakker, E., Blonden, L. A. J., Ginjaar, H. B., Wapenaar, M. C., van Paassen, H. M. B., Broeckhoven, C. V., Pearson, P. L., & van Ommen, G. B. (1989) · Europe PMC (PubMed Central) · Cited by 568
Glycoprotein Complex Anchoring Dystrophin to Sarcolemma1
Yoshida, M., & Ozawa, E. (1990) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a123276 · Cited by 503
Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention
Moser, H. (1984) · Human Genetics · doi:10.1007/bf00275183 · Cited by 413
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse
Mann, C. J., Honeyman, K., Cheng, A. J., Ly, T., Lloyd, F., Fletcher, S., Morgan, J. E., Partridge, T. A., & Wilton, S. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.42 · Cited by 388
Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells
van Deutekom, J. C. T. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.15.1547 · Cited by 293
Dunckley, M. G., Manoharan, M., Villiet, P., Eperon, I. C., & Dickson, G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1083 · Cited by 255
Wilton, S. D., Lloyd, F., Carville, K., Fletcher, S., Honeyman, K., Agrawal, S., & Kole, R. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00010-3 · Cited by 217
Lu, Q. L., Morris, G. E., Wilton, S. D., Ly, T., Artem'yeva, O. V., Strong, P., & Partridge, T. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.5.985 · Cited by 197
Schaal, T. D., & Maniatis, T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.261 · Cited by 196
Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease
Havenga, M. J. E., Lemckert, A. A. C., Ophorst, O. J. A. E., van Meijer, M., Germeraad, W. T. V., Grimbergen, J., van den Doel, M. A., Vogels, R., van Deutekom, J., Janson, A. A. M., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4612-4620.2002 · Cited by 192
Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy
Aartsma-Rus, A., Bremmer-Bout, M., Janson, A. A. M., den Dunnen, J. T., van Ommen, G.-J. B., & van Deutekom, J. C. T. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00086-x · Cited by 175
Self-citationMultiplex Western Blotting System for the Analysis of Muscular Dystrophy Proteins
Anderson, L. V. B., & Davison, K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65354-0 · Cited by 172
Klein, C. J., Coovert, D. D., Bulman, D. E., Ray, P. N., Mendell, J. R., & Burghes, A. H. M. (1992) · PubMed · Cited by 162
Shiga, N., Takeshima, Y., Sakamoto, H., Inoue, K., Yokota, Y., Yokoyama, M., & Matsuo, M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119757 · Cited by 152
Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD.
Murry, C. E., Kay, M. A., Bartosek, T., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119030 · Cited by 145
Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?
Kerr, T. P., Sewry, C. A., Robb, S. A., & Roberts, R. G. (2001) · Human Genetics · doi:10.1007/s004390100598 · Cited by 142
Mann, C. J., Honeyman, K., McClorey, G., Fletcher, S., & Wilton, S. D. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.295 · Cited by 140
Pramono, Z. A. D., Takeshima, Y., Alimsardjono, H., Ishii, A., Takeda, S., & Matsuo, M. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1375 · Cited by 139
Angelis, F. G. D., Sthandier, O., Berarducci, B., Toso, S., Galluzzi, G., Ricci, E., Cossu, G., & Bozzoni, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142302299 · Cited by 136
Cardiac involvement in becker muscular dystrophy
Melacini, P., Fanin, M., Danieli, G. A., Fasoli, G., Villanova, C., Angelini, C. I., Vitiello, L., Miorelli, M., Buja, G., Mostacciuolo, M. L., et al. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90781-u · Cited by 133
Takeshima, Y., Nishio, H., Sakamoto, H., Nakamura, H., & Matsuo, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117693 · Cited by 130
Shashi, V., Clark, P. A., Rogol, A. D., et al. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320570107 · Cited by 116
Exon skipping and translation in patients with frameshift deletions in the dystrophin gene.
Sherratt, T. G., Vulliamy, T., Dubowitz, V., Sewry, C. A., & Strong, P. N. (1993) · Europe PMC (PubMed Central) · Cited by 103
Takeshima, Y., Wada, H., Yagi, M., et al. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00326-6 · Cited by 80
Melis, M., Cau, M., Muntoni, F., Mateddu, A., Galanello, R., Boccone, L., Deidda, F., Loi, D., & Cao, A. (1998) · European Journal of Paediatric Neurology · doi:10.1016/s1090-3798(98)80039-1 · Cited by 71
Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy.
Nicholson, L. V. B., Johnson, M. A., Bushby, K. M. D., & Gardner‐Medwin, D. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.5.632 · Cited by 56
Matsumura, K., Burghes, A. H. M., Mora, M., Tomé, F. M. S., Morandi, L. O., Cornello, F., Leturcq, F., Jeanpierre, M., Jc, K., & Reinert, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116989 · Cited by 51
Vainzof, M., Passos-Bueno, M. R., Takata, R. I., Pavanello, R. C. M., & Zatz, M. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90189-6 · Cited by 25
Progress in gene therapy for Duchenne muscular dystrophy
Clemens, P. R., & Duncan, F. J. (2001) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-001-0080-0 · Cited by 6
Cited by
Cell-Penetrating Peptides: From Basic Research to Clinics
Guidotti, G., Brambilla, L., & Rossi, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.01.003 · Cited by 1,147
Dystrophin and mutations: one gene, several proteins, multiple phenotypes
Muntoni, F., Torelli, S., & Ferlini, A. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00585-4 · Cited by 1,124
Local Dystrophin Restoration with Antisense Oligonucleotide PRO051
van Deutekom, J. C., Janson, A. A., Ginjaar, I. B., Frankhuizen, W. S., Aartsma-Rus, A., Bremmer-Bout, M., den Dunnen, J. T., Koop, K., van der Kooi, A. J., Goemans, N. M., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073108 · Cited by 781
Self-citationThe TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
Bladen, C. L., Salgado, D., Monges, S., Foncuberta, M. E., Kekou, K., Kosma, K., Dawkins, H., Lamont, L., Roy, A. J., Chamova, T., et al. (2015) · Human Mutation · doi:10.1002/humu.22758 · Cited by 729
Self-citationSystemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Goemans, N. M., Tulinius, M., van den Akker, J. T., Burm, B. E., Ekhart, P. F., Heuvelmans, N., Holling, T., Janson, A. A., Platenburg, G. J., Sipkens, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011367 · Cited by 678
Self-citation
Metadata
- Authors
- Aartsma-Rus, A.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-15
- Volume
- 12
- Issue
- 8
- Pages
- 907-914
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2172085519
- Cited by
- 253
- References
- 39
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.